Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Wagner

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
BMC Cancer|September 1, 2017
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapyTalal Hilal, Mary Nakazawa, Jacob Hodskins, et al.
Communications Medicine|August 2, 2024
Robotic scrub nurse to anticipate surgical instruments based on real-time laparoscopic video analysisLars Wagner, Sara Jourdan, Leon Mayer, et al.
Journal of Adolescent and Young Adult Oncology|April 8, 2024
Adoption as an Alternative Family-Building Strategy: Perceptions of Female, Young Adult Cancer Survivors Receiving Gonadotoxic TreatmentsCaroline S Dorfman, Juliann M Stalls, Nicole A Arrato, et al.
Pediatric Blood & Cancer|May 7, 2011
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutationsKasiani Myers, Stella M Davies, Richard E Harris, et al.
Biochimica Et Biophysica Acta|August 31, 2014
Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid supportLinn Petersson, Lars Wagner Städe, Mattias Brofelth, et al.
Cancer|March 22, 2017
Treatment pathway of bone sarcoma in children, adolescents, and young adultsDamon R Reed, Masanori Hayashi, Lars Wagner, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Journal of Adolescent and Young Adult Oncology|March 20, 2026
Development of a Novel Psychosocial Intervention to Improve Symptom Management for Adolescents and Young Adults with Advanced or Recurrent CancerCaroline S Dorfman, Tamara J Somers, Nicole A Arrato, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium studyLindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) TrialSteven G DuBois, Araz Marachelian, Elizabeth Fox, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
BMC Cancer|September 1, 2017
Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapyTalal Hilal, Mary Nakazawa, Jacob Hodskins, et al.
Communications Medicine|August 2, 2024
Robotic scrub nurse to anticipate surgical instruments based on real-time laparoscopic video analysisLars Wagner, Sara Jourdan, Leon Mayer, et al.
Journal of Adolescent and Young Adult Oncology|April 8, 2024
Adoption as an Alternative Family-Building Strategy: Perceptions of Female, Young Adult Cancer Survivors Receiving Gonadotoxic TreatmentsCaroline S Dorfman, Juliann M Stalls, Nicole A Arrato, et al.
Pediatric Blood & Cancer|May 7, 2011
The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutationsKasiani Myers, Stella M Davies, Richard E Harris, et al.
Biochimica Et Biophysica Acta|August 31, 2014
Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid supportLinn Petersson, Lars Wagner Städe, Mattias Brofelth, et al.
Cancer|March 22, 2017
Treatment pathway of bone sarcoma in children, adolescents, and young adultsDamon R Reed, Masanori Hayashi, Lars Wagner, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Journal of Adolescent and Young Adult Oncology|March 20, 2026
Development of a Novel Psychosocial Intervention to Improve Symptom Management for Adolescents and Young Adults with Advanced or Recurrent CancerCaroline S Dorfman, Tamara J Somers, Nicole A Arrato, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium studyLindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2016
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) TrialSteven G DuBois, Araz Marachelian, Elizabeth Fox, et al.
Pageof 5